Genzyme and Cystic Fibrosis Foundation Therapeutics Announce Collaboration to Discover New CF Drugs
New effort will search for potential therapies targeting the most common mutation of cystic fibrosis
18-Nov-2011 -
Genzyme, a Sanofi company, and Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic Fibrosis Foundation, announced a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.The ...
cystic fibrosis
drug discovery
Genzyme
+1